KUKJEON PHARMACEUTICAL Co.,Ltd Logo

KUKJEON PHARMACEUTICAL Co.,Ltd

Develops and manufactures APIs and chemical materials for the electronics industry.

307750 | KO

Overview

Corporate Details

ISIN(s):
KR7307750000
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 학의로 282 B동 1516호 (관양동,금강펜테리움), 안양시

Description

KUKJEON PHARMACEUTICAL Co., Ltd. is a chemical total solution provider specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs). The company's portfolio includes raw materials for specialized medicines such as choline alfoscerates, benfothiamines, and napamostat. A key product is Itopride hydrochloride, a functional indigestion treatment, for which the company holds a proprietary manufacturing patent. In addition to its pharmaceutical focus, the company also develops and supplies chemical materials for the electronics industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-02-14 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.9 KB
2023-02-07 00:00
주식등의대량보유상황보고서(일반)
Korean 113.5 KB
2023-01-04 00:00
주식등의대량보유상황보고서(일반)
Korean 111.9 KB
2022-12-15 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2022-12-13 00:00
주식등의대량보유상황보고서(일반)
Korean 111.9 KB
2022-12-07 00:00
주식등의대량보유상황보고서(일반)
Korean 111.7 KB
2022-12-02 00:00
주식등의대량보유상황보고서(일반)
Korean 111.7 KB
2022-11-16 00:00
주식등의대량보유상황보고서(일반)
Korean 111.8 KB
2022-11-14 00:00
분기보고서 (2022.09)
Korean 1.4 MB
2022-11-07 00:00
주식등의대량보유상황보고서(일반)
Korean 111.7 KB
2022-10-07 00:00
주식등의대량보유상황보고서(일반)
Korean 111.8 KB
2022-09-26 00:00
[기재정정]주요사항보고서(유형자산양수결정)
Korean 15.1 KB
2022-09-23 00:00
주식등의대량보유상황보고서(일반)
Korean 111.7 KB
2022-09-16 00:00
증권발행결과(자율공시)(제2회차 CB)
Korean 5.6 KB
2022-09-14 00:00
주요사항보고서(전환사채권발행결정)
Korean 71.9 KB

Automate Your Workflow. Get a real-time feed of all KUKJEON PHARMACEUTICAL Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KUKJEON PHARMACEUTICAL Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KUKJEON PHARMACEUTICAL Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.